KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Current Leases (2019 - 2025)

Biolife Solutions (BLFS) has disclosed Current Leases for 7 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Current Leases rose 53.74% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, up 53.74% year-over-year, with the annual reading at $2.2 million for FY2025, 53.74% up from the prior year.
  • Current Leases for Q4 2025 was $2.2 million at Biolife Solutions, up from $2.2 million in the prior quarter.
  • The five-year high for Current Leases was $2.9 million in Q1 2023, with the low at $114000.0 in Q1 2021.
  • Average Current Leases over 5 years is $1.5 million, with a median of $1.6 million recorded in 2024.
  • The sharpest move saw Current Leases soared 2351.75% in 2022, then plummeted 87.89% in 2024.
  • Over 5 years, Current Leases stood at $149000.0 in 2021, then grew by 6.04% to $158000.0 in 2022, then soared by 713.92% to $1.3 million in 2023, then rose by 13.45% to $1.5 million in 2024, then surged by 53.74% to $2.2 million in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $2.2 million, $2.2 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.